{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:46:23Z","timestamp":1791225983123,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Health Department of \u201cGobierno de Navarra\u201d","award":["28\/2007"],"award-info":[{"award-number":["28\/2007"]}]},{"DOI":"10.13039\/501100004587","name":"\u201cInstituto de Salud Carlos III\u201d","doi-asserted-by":"crossref","award":["PS09\/01083"],"award-info":[{"award-number":["PS09\/01083"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"\u201cInstituto de Salud Carlos III\u201d","doi-asserted-by":"crossref","award":["PI12\/01358"],"award-info":[{"award-number":["PI12\/01358"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"\u201cInstituto de Salud Carlos III\u201d","doi-asserted-by":"crossref","award":["FI08\/00432"],"award-info":[{"award-number":["FI08\/00432"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.vaccine.2013.05.020","type":"journal-article","created":{"date-parts":[[2013,5,31]],"date-time":"2013-05-31T07:01:01Z","timestamp":1369983661000},"page":"3288-3294","source":"Crossref","is-referenced-by-count":74,"title":["Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice"],"prefix":"10.1016","volume":"31","author":[{"given":"A.I.","family":"Camacho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Irache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"S\u00e1nchez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gamazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2013.05.020_bib0005","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.3201\/eid1611.090934","article-title":"Decrease in shigellosis-related deaths without Shigella spp.-specific interventions, Asia","volume":"16","author":"Bardhan","year":"2010","journal-title":"Emerg. Infect. Dis."},{"issue":"8","key":"10.1016\/j.vaccine.2013.05.020_bib0010","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"Kotloff","year":"1999","journal-title":"Bull World Health Organ"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2013.05.020_bib0015","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.1371\/journal.pmed.0030354","article-title":"Shigellosis: an old disease in new clothes?","volume":"3","author":"Sansonetti","year":"2006","journal-title":"PLoS Med."},{"issue":"October (46)","key":"10.1016\/j.vaccine.2013.05.020_bib0020","doi-asserted-by":"crossref","first-page":"8222","DOI":"10.1016\/j.vaccine.2011.08.121","article-title":"Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice","volume":"29","author":"Camacho","year":"2011","journal-title":"Vaccine"},{"issue":"December (11)","key":"10.1016\/j.vaccine.2013.05.020_bib0025","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.4049\/jimmunol.0901466","article-title":"What role does the route of immunization play in the generation of protective immunity against mucosal pathogens?","volume":"183","author":"Belyakov","year":"2009","journal-title":"J Immunol"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2013.05.020_bib0030","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.coi.2011.03.009","article-title":"Defending the mucosa: adjuvant and carrier formulations for mucosal immunity","volume":"23","author":"Lawson","year":"2011","journal-title":"Curr Opin Immunol"},{"issue":"March (15)","key":"10.1016\/j.vaccine.2013.05.020_bib0035","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.vaccine.2004.11.010","article-title":"Mucosal adjuvants","volume":"23","author":"Freytag","year":"2005","journal-title":"Vaccine"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2013.05.020_bib0040","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.vaccine.2011.11.003","article-title":"New insights in mucosal vaccine development","volume":"30","author":"Pavot","year":"2012","journal-title":"Vaccine"},{"issue":"July (13\u201314)","key":"10.1016\/j.vaccine.2013.05.020_bib0045","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.drudis.2011.04.006","article-title":"Particulate vaccines: on the quest for optimal delivery and immune response","volume":"16","author":"De Temmerman","year":"2011","journal-title":"Drug Discov Today"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.05.020_bib0050","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1039\/B914943K","article-title":"Designing polymeric particles for antigen delivery","volume":"40","author":"De Koker","year":"2011","journal-title":"Chem Soc Rev"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.05.020_bib0055","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2567.2005.02268.x","article-title":"Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles","volume":"117","author":"Shen","year":"2006","journal-title":"Immunology"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2013.05.020_bib0060","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0169-409X(02)00050-9","article-title":"Polyanhydrides: an overview","volume":"54","author":"Kumar","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2013.05.020_bib0065","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1016\/j.actbio.2011.03.023","article-title":"Polyanhydride microparticles enhance dendritic cell antigen presentation and activation","volume":"7","author":"Torres","year":"2011","journal-title":"Acta Biomater"},{"issue":"October (28)","key":"10.1016\/j.vaccine.2013.05.020_bib0070","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.1016\/j.biomaterials.2011.05.063","article-title":"Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants","volume":"32","author":"Petersen","year":"2011","journal-title":"Biomaterials"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.05.020_bib0075","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s11095-008-9760-7","article-title":"Polymer chemistry influences monocytic uptake of polyanhydride nanospheres","volume":"26","author":"Ulery","year":"2009","journal-title":"Pharm Res"},{"issue":"September (9\u201310)","key":"10.1016\/j.vaccine.2013.05.020_bib0080","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1166\/jnn.2006.471","article-title":"Development of a novel vaccine delivery system based on Gantrez nanoparticles","volume":"6","author":"Gomez","year":"2006","journal-title":"J Nanosci Nanotechnol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2013.05.020_bib0085","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1128\/CVI.00164-10","article-title":"Poly(anhydride) nanoparticles act as active Th1 adjuvants through Toll-like receptor exploitation","volume":"17","author":"Tamayo","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.05.020_bib0090","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/10010126","article-title":"Bioadhesive properties of Gantrez nanoparticles","volume":"10","author":"Irache","year":"2005","journal-title":"Molecules"},{"issue":"May (22)","key":"10.1016\/j.vaccine.2013.05.020_bib0095","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1016\/j.vaccine.2007.03.025","article-title":"Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella enteritidis in mice","volume":"25","author":"Ochoa","year":"2007","journal-title":"Vaccine"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2013.05.020_bib0100","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1007\/s11095-012-0791-8","article-title":"Toxicity studies of poly(anhydride) nanoparticles as carriers for oral drug delivery","volume":"29","author":"Ojer","year":"2012","journal-title":"Pharm Res"},{"issue":"October","key":"10.1016\/j.vaccine.2013.05.020_bib0105","article-title":"Towards a non-living vaccine against Shigella flexneri: from the inactivation procedure to protection studies","author":"Camacho","year":"2012","journal-title":"Methods"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2013.05.020_bib0110","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrmicro1662","article-title":"Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road","volume":"5","author":"Levine","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2013.05.020_bib0115","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1586\/erv.09.127","article-title":"Inactivated and subunit vaccines to prevent shigellosis","volume":"8","author":"Kaminski","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2013.05.020_bib0120","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1586\/14760584.5.5.669","article-title":"Live-attenuated Shigella vaccines","volume":"5","author":"Venkatesan","year":"2006","journal-title":"Expert Rev Vaccines"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2013.05.020_bib0125","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1128\/AAC.42.6.1476","article-title":"Delivery of the non-membrane-permeative antibiotic gentamicin into mammalian cells by using Shigella flexneri membrane vesicles","volume":"42","author":"Kadurugamuwa","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"February (5)","key":"10.1016\/j.vaccine.2013.05.020_bib0130","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.molimm.2006.04.007","article-title":"Porin of Shigella dysenteriae activates mouse peritoneal macrophage through Toll-like receptors 2 and 6 to induce polarized type I response","volume":"44","author":"Biswas","year":"2007","journal-title":"Mol Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2013.05.020_bib0135","doi-asserted-by":"crossref","first-page":"e22663","DOI":"10.1371\/journal.pone.0022663","article-title":"Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model","volume":"6","author":"Pore","year":"2011","journal-title":"PLoS ONE"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2013.05.020_bib0140","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/JCM.29.2.386-389.1991","article-title":"Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis","volume":"29","author":"Cohen","year":"1991","journal-title":"J Clin Microbiol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2013.05.020_bib0145","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1128\/IAI.59.7.2341-2350.1991","article-title":"Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides","volume":"59","author":"Oberhelman","year":"1991","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2013.05.020_bib0150","doi-asserted-by":"crossref","first-page":"e8223","DOI":"10.1371\/journal.pone.0008223","article-title":"The immunogenic SigA enterotoxin of Shigella flexneri 2a binds to HEp-2 cells and induces fodrin redistribution in intoxicated epithelial cells","volume":"4","author":"Al-Hasani","year":"2009","journal-title":"PLoS ONE"},{"issue":"March (13)","key":"10.1016\/j.vaccine.2013.05.020_bib0155","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.vaccine.2005.11.040","article-title":"Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine","volume":"24","author":"Oaks","year":"2006","journal-title":"Vaccine"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.05.020_bib0160","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1128\/IAI.06174-11","article-title":"Broadly protective Shigella vaccine based on type III secretion apparatus proteins","volume":"80","author":"Martinez-Becerra","year":"2012","journal-title":"Infect Immun"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2013.05.020_bib0165","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.20051720","article-title":"Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity","volume":"203","author":"Querec","year":"2006","journal-title":"J Exp Med"},{"issue":"July (6996)","key":"10.1016\/j.vaccine.2013.05.020_bib0170","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nature02761","article-title":"Inferences, questions and possibilities in Toll-like receptor signalling","volume":"430","author":"Beutler","year":"2004","journal-title":"Nature"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2013.05.020_bib0175","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat Immunol"},{"issue":"September (41)","key":"10.1016\/j.vaccine.2013.05.020_bib0180","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1016\/j.vaccine.2011.05.072","article-title":"Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators","volume":"29","author":"Camacho","year":"2011","journal-title":"Vaccine"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2013.05.020_bib0185","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/sj.icb7100025","article-title":"Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival?","volume":"85","author":"Phalipon","year":"2007","journal-title":"Immunol Cell Biol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.05.020_bib0190","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1128\/IAI.63.1.289-296.1995","article-title":"Persistence of local cytokine production in shigellosis in acute and convalescent stages","volume":"63","author":"Raqib","year":"1995","journal-title":"Infect Immun"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2013.05.020_bib0195","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.4049\/jimmunol.164.4.2221","article-title":"Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain","volume":"164","author":"Samandari","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.05.020_bib0200","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1146\/annurev.iy.12.040194.004313","article-title":"The CD40 antigen and its ligand","volume":"12","author":"Banchereau","year":"1994","journal-title":"Annu Rev Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2013.05.020_bib0205","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1084\/jem.179.2.757","article-title":"Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3","volume":"179","author":"Briere","year":"1994","journal-title":"J Exp Med"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2013.05.020_bib0210","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1128\/IAI.67.2.782-788.1999","article-title":"Strategy for cross-protection among Shigella flexneri serotypes","volume":"67","author":"Noriega","year":"1999","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13005987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13005987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T10:59:46Z","timestamp":1595847586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13005987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":42,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0264410X13005987"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}